Aeglea BioTherapeutics Announces Proposed Public Offering
AUSTIN, Texas, Feb. 9, 2022 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (Nasdaq:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeut…
More from Central Texas
Mary Hardin–Baylor Crusaders
Women's Golf in First after round one of the Golfweek October Classic
Central Texas
•
27m ago
KWHI Radio Brenham Sports
FIELD GOAL TROUBLE CAUSES BLINN FOOTBALL TO LOSE TO CISCO IN 2-OT
Central Texas
•
2h ago
Killeen Daily Herald
Killeen ISD projects create new opportunities for Central Texas contractors
Central Texas
•
2h ago
Killeen Daily Herald
More than 600 turn out for Killeen NAACP's 15th annual breast cancer walk
Central Texas
•
2h ago
Killeen Daily Herald
CTC HVAC program sees record enrollment following instructional changes
Central Texas
•
5h ago
